Argent Advisors’s Boston Scientific BSX Stock Holding History

Argent Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7	Closed	–	–	174
2019 Q4	$0	Buy	+7	New	+$293	﹤0.01%	497

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Argent Advisors's BSX Position: Q1 2020 in Review

Argent Advisors sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 7 shares.

Argent Advisors first reported a position in BSX in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

Argent Advisors reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
Argent Advisors sold 7 Boston Scientific shares in Q1 2020.
Argent Advisors first reported a position in Boston Scientific in Q4 2019 and held it in 1 quarter.
Argent Advisors's Boston Scientific position peaked at $0 in Q4 2019.
800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Argent Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.